AAAAAA
Results:
1-13
|
Results: 13
Authors:
Fukada, J
Kurimoto, Y
Ruiz, P
Aitouche, A
Zeevi, A
Li, S
Kubota, T
Pham, SM
Citation: J. Fukada et al., Long-term survival of rat cardiac allografts by intrathymic plus portal venous injections of donor bone marrow cells and short-term tacrolimus immunosuppression, TRANSPLAN I, 14(5), 2001, pp. 311-319
Authors:
Li, S
Thanikachalam, M
Pang, M
Carreno, M
Aitouche, A
Pham, SM
Citation: S. Li et al., Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism, EXP HEMATOL, 29(4), 2001, pp. 534-541
Authors:
Fukada, J
Schena, S
Tack, I
Ruiz, P
Kurimoto, Y
Pang, M
Aitouche, A
Abe, T
Striker, LJ
Pham, SM
Citation: J. Fukada et al., Nitric oxide donor FK409 attenuates the development of neointimal hyperplasia in a rat aortic allograft model, TRANSPLAN P, 33(1-2), 2001, pp. 536-537
Authors:
Li, S
Thanikachalam, M
Pang, MH
Kawaharada, N
Aitouche, A
Pham, SM
Citation: S. Li et al., A clinically relevant CTLA4-Ig-based regimen induces chimerism and tolerance to heart grafts, ANN THORAC, 72(4), 2001, pp. 1306-1310
Authors:
Yoshimura, R
Chargui, J
Aitouche, A
Veyron, P
Touraine, JL
Citation: R. Yoshimura et al., Induction of hyperacute rejection of skin allografts by CD8(+) lymphocytes, TRANSPLANT, 69(7), 2000, pp. 1452-1457
Authors:
Fukada, J
Schena, S
Tack, I
Ruiz, P
Kurimoto, Y
Pang, M
Aitouche, A
Abe, T
Striker, LJ
Pham, SM
Citation: J. Fukada et al., FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model, CIRCUL RES, 87(1), 2000, pp. 66-72
Authors:
Cicalese, L
Aitouche, A
Ploskina, TM
Ford, HR
Rao, AS
Citation: L. Cicalese et al., The role of laparotomy, gut manipulation and immunosuppression on bacterial translocation from the intestinal tract, TRANSPLAN P, 31(4), 1999, pp. 1922-1923
Authors:
Rao, AS
Shapiro, R
Corry, R
Dodson, F
Abu-Elmagd, K
Pham, S
Jordan, M
Salgar, S
Zeevi, A
Rastellini, C
Ostrowski, L
Aitouche, A
Keenan, R
Reyes, J
Griffith, B
Starzl, TE
Fung, JJ
Citation: As. Rao et al., Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions, TRANSPLAN P, 31(1-2), 1999, pp. 700-701
Authors:
Salam, A
Aitouche, A
Kuddus, R
Peach, R
Fung, JJ
Rao, AS
Citation: A. Salam et al., The combined use of sublethal irradiation and costimulatory blockade to generate mixed bone marrow chimeras, TRANSPLAN P, 31(1-2), 1999, pp. 1197-1198
Authors:
Rastellini, C
Salam, A
Kuddus, R
Aitouche, A
Subbotin, V
Braun, M
Leach, R
Peach, R
Fung, JJ
Starzl, TE
Rao, AS
Citation: C. Rastellini et al., Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival, TRANSPLAN P, 31(1-2), 1999, pp. 1242-1243
Authors:
Tang, JL
Aitouche, A
Subbotin, V
Salam, A
Sun, H
Gandhi, C
Valdivia, LA
Fung, JJ
Starzl, TE
Rao, AS
Citation: Jl. Tang et al., Endothelin-1 receptor blockade and its effect on chronic rejection, TRANSPLAN P, 31(1-2), 1999, pp. 1249-1249
Authors:
Subbotin, V
Sun, H
Aitouche, A
Salam, A
Valdivia, LA
Fung, JJ
Starzl, TE
Rao, AS
Citation: V. Subbotin et al., The role of Fas/FasL apoptotic pathway in the development of chronic rejection, TRANSPLAN P, 31(1-2), 1999, pp. 1397-1398
Authors:
Subbotin, V
Sun, H
Aitouche, A
Salam, A
Valdivia, LA
Fung, JJ
Starzl, TE
Rao, AS
Citation: V. Subbotin et al., Marked mitigation of transplant vascular sclerosis in FasL(gld) (CD95L) mutant recipients - The role of alloantibodies in the development of chronic rejection, TRANSPLANT, 67(10), 1999, pp. 1295-1300
Risultati:
1-13
|